TY - JOUR
T1 - Potential mouse tumor model for pre-clinical testing of Mage-specific breast cancer vaccines
AU - Sypniewska, Roza K.
AU - Hoflack, Lieve
AU - Bearss, David J.
AU - Gravekamp, Claudia
N1 - Funding Information:
We are grateful to Dr Jolene Windle for providing the MMTV-ras and MMTV-myc-induced mammary tumors, to Ms Mary Robinson for her assistance with the preparation of the figures in the manuscript, Dr Robert Reddick for his critical analysis of immunohistochemical results, and Dr Jan Vijg for the fruitful discussions. This work was supported by the Barbara H. Bowman, Award in Cancer Prevention Research from the San Antonio Cancer Institute (SACI), NIH grant RO3 AG18564, AFAR A000106, and NIA training grant 5 T32 AG000205-09.
PY - 2002
Y1 - 2002
N2 - Currently, there is a lack of suitable pre-clinical mouse models for testing and optimization of experimental cancer vaccines. Here, in situ developed mammary tumors of MMTV-v-Ha-ras and MMTV-c-myc transgenic mice and normal mammary, liver, spleen, and testis were screened for expression of tumor-associated antigens (TAA) Mage-b1/2/3 by reverse-transcriptase polymerase chain reaction (RT-PCR) and Southern blot hybridization. Mage-b1/2/3 are homologues of the human TAA MAGE-B1/2/3. Expression of these human MAGE genes has been found in tumors of various histological types, including breast cancer [39]. Mage-specific RT-PCR products (using primers that amplify all three Mage-b1/2/3) were detected in mammary tumors of the MMTV-v-Ha-ras and MMTV-c-myc transgenic mice and in testis, but not in other normal tissues. RT-PCR products obtained from the mammary tumors (using primers that amplify the complete protein-encoding region of Mage-b1/2/3) were cloned and sequenced, and appeared to be most homologous with Mage-b3. Comparison of the Mage-b3 gene in mammary tumors and normal tissues suggest that somatic mutations did not occur in the Mage-b3 gene of the ras- and myc-induced mammary tumors. In addition, no differences were found between the Mage-b3 cDNA of testis, the only normal tissue that expresses Mage-b3, and Mage-b3 in genomic DNA of normal kidney, where Mage-b3 is silent. The MMTV-v-Ha-ras and MMTV-c-myc transgenic mice of this study are the first immune competent mouse models with in situ developed mammary tumors in which the expression of Mage-b3 TAA has been demonstrated. This makes them potentially suitable as a mouse model for pre-clinical testing of Mage-specific cancer vaccines in vivo.
AB - Currently, there is a lack of suitable pre-clinical mouse models for testing and optimization of experimental cancer vaccines. Here, in situ developed mammary tumors of MMTV-v-Ha-ras and MMTV-c-myc transgenic mice and normal mammary, liver, spleen, and testis were screened for expression of tumor-associated antigens (TAA) Mage-b1/2/3 by reverse-transcriptase polymerase chain reaction (RT-PCR) and Southern blot hybridization. Mage-b1/2/3 are homologues of the human TAA MAGE-B1/2/3. Expression of these human MAGE genes has been found in tumors of various histological types, including breast cancer [39]. Mage-specific RT-PCR products (using primers that amplify all three Mage-b1/2/3) were detected in mammary tumors of the MMTV-v-Ha-ras and MMTV-c-myc transgenic mice and in testis, but not in other normal tissues. RT-PCR products obtained from the mammary tumors (using primers that amplify the complete protein-encoding region of Mage-b1/2/3) were cloned and sequenced, and appeared to be most homologous with Mage-b3. Comparison of the Mage-b3 gene in mammary tumors and normal tissues suggest that somatic mutations did not occur in the Mage-b3 gene of the ras- and myc-induced mammary tumors. In addition, no differences were found between the Mage-b3 cDNA of testis, the only normal tissue that expresses Mage-b3, and Mage-b3 in genomic DNA of normal kidney, where Mage-b3 is silent. The MMTV-v-Ha-ras and MMTV-c-myc transgenic mice of this study are the first immune competent mouse models with in situ developed mammary tumors in which the expression of Mage-b3 TAA has been demonstrated. This makes them potentially suitable as a mouse model for pre-clinical testing of Mage-specific cancer vaccines in vivo.
KW - CTL epitopes
KW - Cancer vaccines
KW - Mage-b3
KW - Mouse mammary tumor models
KW - Pre-clinical testing of cancer vaccines
KW - Transgenic mice
UR - http://www.scopus.com/inward/record.url?scp=0035990972&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035990972&partnerID=8YFLogxK
U2 - 10.1023/A:1016367104015
DO - 10.1023/A:1016367104015
M3 - Article
C2 - 12211215
AN - SCOPUS:0035990972
SN - 0167-6806
VL - 74
SP - 221
EP - 233
JO - Breast Cancer Research and Treatment
JF - Breast Cancer Research and Treatment
IS - 3
ER -